Comparison of the incidence of adverse reactions between herbal decoction and Chinese patent medicine combined with western medicine in treatment of COVID-19: A protocol for systematic review and meta-analysis
Authors:
Open Access
- 9 December 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (49) , e32255
Abstract
Introduction: Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease that has led to millions of confirmed cases and deaths worldwide. Traditional Chinese Medicine plays an irreplaceable role in the treatment and prevention of epidemics in China. Western medicine improves clinical symptoms as well as bringing many adverse reactions. The combination of Chinese and western medicine can significantly improve the clinical symptoms and efficacy of patients. Currently, there is a lack of systematic reviews on the comparison of the incidence of adverse reactions between the difference treatments. We conducted this study to evaluate the comparison of the incidence of adverse reactions between herbal decoction and Chinese patent medicine combined with western medicine in treatment of COVID-19. Methods and analysis: Randomized controlled trials in 9 databases from December 2019 to September 2022, will be included, without language restrictions. Two independent researchers will screen and select studies, extract data, and evaluate the study quality. The Cochrane risk-of-bias tool for randomized controlled trials will be used to assess the risk of bias in the included studies. Statistical analyses will be conducted using Review Manager. Results: Our findings will compare the incidence of adverse reactions between herbal decoction and Chinese patent medicine combined with western medicine in treatment of COVID-19, which will be disseminated in a relevant conference and published in a peer-reviewed publication. Ethics and dissemination: This study will not include personal information. Ethical approval is not required for this study. PROSPERO registration number: CRD42022371001.Keywords
This publication has 11 references indexed in Scilit:
- Coronavirus Disease 2019–COVID-19Clinical Microbiology Reviews, 2020
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)International Journal of Surgery, 2020
- Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inactionBMJ, 2020
- Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concernEurosurveillance, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- [Systematic review of efficacy and safety of Lianhua Qingwen Capsules in treatment of viral influenza].2019
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Best Practices in Public Health Risk and Crisis CommunicationJournal of Health Communication, 2003
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997